Canopy Biosciences, LLC — Form D
Canopy Biosciences, LLC of SAINT LOUIS, MO, a company, filed a Form D exempt-offering notice with the SEC on 2018-01-03. The offering totals $3.4M, of which $2.1M was reported sold. Industry: Biotechnology.
Offering
- Filed: 2018-01-03
- Form: D
- Accession: 0001712948-18-000001
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $3.4M
- Amount sold: $2.1M
- Remaining: $1.3M
- Minimum investment: $20K
- Investors: 16
- Date of first sale: 2017-12-20
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-302234
Issuer
- Name: Canopy Biosciences, LLC
- CIK: 0001712948
- Entity type: Limited Liability Company
- Jurisdiction: DELAWARE
- Incorporated: 2016
- Address: 4320 FOREST PARK AVENUE, SAINT LOUIS, MO, 63108
- Phone: 314-615-6325
Officers, directors & promoters (6)
| Name | Role | Location |
|---|
| Charles Bolten | Director | St. Louis, MO |
| David Kingsley | Director | SOUTH JORDAN, UT |
| David Smoller | Director | St. Louis, MO |
| Edward Weinstein | Director | St. Louis, MO |
| Edward Weinstein | Executive Officer | St. Louis, MO |
| Crystal Winkeler | Executive Officer | ST. LOUIS, MO |
Other filings by this issuer (1)
More